Redefine what’s possible in life sciences
In the era of intelligent technologies, organizations must reinvent to bring breakthrough treatments to patients, faster and at lower costs.
Life sciences now
100%
of biopharma executives agree AI foundation models will enable connections across data types, revolutionizing where and how AI is used
92%
of biopharma executives agree that technology plays a critical role in all current and future reinvention strategy
90%
of biopharma executives agree that data transparency is becoming a competitive differentiator
60%
of life sciences supply chain executives want better real-time inventory and visibility from external manufacturing partners
How to reinvent life sciences
Working with Medical Technology companies to develop solutions across the patient’s entire healthcare journey.
Drive innovation and productivity. Transform patient outcomes.
Today’s convergence of science and technology drives R&D innovation. With biopharma innovations, your team can meet patient needs more efficiently and affordably.
93%
Increase your odds of success
To make your portfolio more likely to succeed, while decreasing its costs, manage it using New-Science treatments.
Speed the discovery of new therapies
Use design thinking, digital technology and ecosystem partnerships to build collaborative digital labs — enabling you to adopt AI, machine learning and in silico experimentation.
Design better clinical trials
Tap into new methods like decentralized trials and synthetic control arms. Scale AI and machine learning to speed development. Improve accessibility and health equity.
Reinvent commercial models to better meet everyone’s needs
The next era of commercialization brings together insights, design thinking and human ingenuity to modernize the commercial model and drive sustainable growth.
71%
Deliver benefits that matter to all stakeholders
Cultivate value for every participant in the value chain: from patients to healthcare providers; from caregivers to payors.
Invest in a strong commercial core
Set a clear agenda that inspires your organization, making clear how critical it is to advance the core capabilities of marketing and the customer model.
Build efficiency to improve launch success
Make sure operations serve the objectives of both developing medicines that improve patient outcomes and bringing long-term cost savings to the healthcare system.
Get more from your data and AI
Use data and generative AI to enable predictive models for better engagement and quicker decision-making from healthcare providers.
Fulfill patient needs innovatively with original science and tech.
New Science is Accenture’s comprehensive global analysis of regulated scientific treatments in development and on the market.
Scientific novelty
Get a better understanding of managing your portfolio risk and the future growth areas in disease and overall therapeutic areas.
Unmet needs
Classify science using different dimensions to understand its dynamics for patients, biopharma and the market. This will help evaluate the potential of new treatments to benefit patients.
Technology convergence
Measuring medicines that coexist with technology in both the near-term and future ensures a better understanding of science’s growing dependence on intelligent technology.
Cultivate new ways of working, innovating, collaborating and operating
Supercharge science with generative AI: Not your average technology revolution.
1
Start your reinvention journey
2023 was the year of generative AI experimentation and a proliferation of isolated use cases. 2024 will be the year in which companies will start to reinvent the enterprise with generative AI.
Build a supply chain for high-quality therapies and devices
Future-proof your supply chain and operations. Deliver an end-to-end supply chain strategy and transformation.
60%
Relevant and visionary
Agile and customer-centric, your supply chain must address demand changes and scientific advances in a cost-effective way.
Resilient in the making
The modern supply chain prepares for, mitigates and responds to disruptions of all scales It constantly adapts to the ever-increasing complexity of new science.
Use generative AI
Be sustainable and responsible
Convert scientific advances to high-quality medicines available globally. How? By building sustainable value chains, benefiting both society and the planet, while building trust.
Intelligent operations
Delivering a culture of innovation for life sciences organizations
Delivering high quality services through our people, powered by technology
We combine our pharmacovigilance, regulatory and clinical operations talent within our global delivery centers, powered by intelligent technology solutions, to fulfill our client operational needs.
What’s trending in life sciences
Awards and recognition
Market Leader in Horizon 3 Life Sciences Service Providers Report
Position #1: Life Sciences Smart Manufacturing Services Lead
Our leaders
Petra Jantzer, Ph.D.
Senior Managing Director – Global Life Sciences Lead
Ramon Pressburger
Managing Director – North America Lead and Strategy Lead, Global Life Sciences
Jan Ising
Managing Director – Europe, Global Life Sciences
Daishi Miyao
Managing Director – Growth Markets, Global Life Sciences